Market Share of Global Myeloproliferative Disorders (MPD) Treatment Industry
The myeloproliferative disorders (MPD) treatment market is consolidated in nature due to the presence of a few key companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including AbbVie, Bristol-Myers Squibb, Incyte Corporation, Mylan NV, Novartis AG, and Pfizer among others.
Myeloproliferative Disorders Treatment Market Leaders
-
Novartis AG
-
Bristol-Myers Squibb
-
Incyte Corporation
-
Takeda Pharmaceutical Company Limited
-
Viatris (Mylan N.V.)
*Disclaimer: Major Players sorted in no particular order
